Bolt Biotherapeutics, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Bolt Biotherapeutics, Inc. (BOLT) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$7.01 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-12
- Bolt Biotherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$7.01M.
- Bolt Biotherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$13.26M.
- Bolt Biotherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$14.53M.
- Bolt Biotherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$18.50M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$7.01M 10-K · filed 2026-03-12 |
| 2024-12-31 | -$13.26M 10-K · filed 2026-03-12 |
| 2023-12-31 | -$14.53M 10-K · filed 2025-03-24 |
| 2022-12-31 | -$18.50M 10-K · filed 2024-03-21 |
| 2021-12-31 | -$20.70M 10-K · filed 2023-03-29 |
| 2020-12-31 | -$12.75M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |